Icon

TRIUMEQ (nda205551)- (EQ 600MG BASE;EQ 50MG BASE;300MG)

ABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE VIIV HLTHCARE
EQ 600MG BASE;EQ 50MG BASE;300MG
Yes No
2030-Jun-08 2018-Aug-12
None None
None No
TRIUMEQ is a combination of dolutegravir (integrase strand transfer inhibitor [INSTI]), abacavir, and lamivudine (both nucleoside analogue reverse transcriptase inhibitors) indicated for the treatment of HIV-1 infection in adults and in pediatric patients weighing at least 10 kg.
0 3 0
Total Other Developers 17
Drugs with Suitability No
EQ 600MG BASE;EQ 50MG BASE;300MG ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.